Cara Therapeutic Stock Market Value
| CARA Stock | USD 0.31 0.01 3.33% |
| Symbol | Cara |
Cara Therapeutic Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cara Therapeutic. If investors know Cara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cara Therapeutic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.75) | Revenue Per Share 0.202 | Quarterly Revenue Growth (0.86) | Return On Assets (0.63) | Return On Equity (1.84) |
The market value of Cara Therapeutic is measured differently than its book value, which is the value of Cara that is recorded on the company's balance sheet. Investors also form their own opinion of Cara Therapeutic's value that differs from its market value or its book value, called intrinsic value, which is Cara Therapeutic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cara Therapeutic's market value can be influenced by many factors that don't directly affect Cara Therapeutic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cara Therapeutic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cara Therapeutic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cara Therapeutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cara Therapeutic 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cara Therapeutic's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cara Therapeutic.
| 10/24/2024 |
| 11/23/2024 |
If you would invest 0.00 in Cara Therapeutic on October 24, 2024 and sell it all today you would earn a total of 0.00 from holding Cara Therapeutic or generate 0.0% return on investment in Cara Therapeutic over 30 days. Cara Therapeutic is related to or competes with Corbus Pharmaceuticals. Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing ... More
Cara Therapeutic Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cara Therapeutic's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cara Therapeutic upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 19.35 | |||
| Value At Risk | (6.90) | |||
| Potential Upside | 7.41 |
Cara Therapeutic Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cara Therapeutic's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cara Therapeutic's standard deviation. In reality, there are many statistical measures that can use Cara Therapeutic historical prices to predict the future Cara Therapeutic's volatility.| Risk Adjusted Performance | 9.0E-4 | |||
| Jensen Alpha | (0.21) | |||
| Total Risk Alpha | (0.75) | |||
| Treynor Ratio | (0.04) |
Cara Therapeutic Backtested Returns
Cara Therapeutic secures Sharpe Ratio (or Efficiency) of -0.04, which signifies that the company had a -0.04% return per unit of risk over the last 3 months. Cara Therapeutic exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cara Therapeutic's Mean Deviation of 3.2, standard deviation of 4.45, and Risk Adjusted Performance of 9.0E-4 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.28, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cara Therapeutic will likely underperform. At this point, Cara Therapeutic has a negative expected return of -0.18%. Please make sure to confirm Cara Therapeutic's value at risk, rate of daily change, relative strength index, as well as the relationship between the kurtosis and market facilitation index , to decide if Cara Therapeutic performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.61 |
Very good reverse predictability
Cara Therapeutic has very good reverse predictability. Overlapping area represents the amount of predictability between Cara Therapeutic time series from 24th of October 2024 to 8th of November 2024 and 8th of November 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cara Therapeutic price movement. The serial correlation of -0.61 indicates that roughly 61.0% of current Cara Therapeutic price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.61 | |
| Spearman Rank Test | -0.41 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Cara Therapeutic lagged returns against current returns
Autocorrelation, which is Cara Therapeutic stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cara Therapeutic's stock expected returns. We can calculate the autocorrelation of Cara Therapeutic returns to help us make a trade decision. For example, suppose you find that Cara Therapeutic has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Cara Therapeutic regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cara Therapeutic stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cara Therapeutic stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cara Therapeutic stock over time.
Current vs Lagged Prices |
| Timeline |
Cara Therapeutic Lagged Returns
When evaluating Cara Therapeutic's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cara Therapeutic stock have on its future price. Cara Therapeutic autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cara Therapeutic autocorrelation shows the relationship between Cara Therapeutic stock current value and its past values and can show if there is a momentum factor associated with investing in Cara Therapeutic.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Cara Therapeutic offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cara Therapeutic's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cara Therapeutic Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cara Therapeutic Stock:Check out Cara Therapeutic Correlation, Cara Therapeutic Volatility and Cara Therapeutic Alpha and Beta module to complement your research on Cara Therapeutic. For information on how to trade Cara Stock refer to our How to Trade Cara Stock guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Cara Therapeutic technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.